WeedLife News Network

Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife News Network.

Smokable hemp, CBD foods, and cannabis use in California hospitals

Marijuana activists in California managed to achieve a couple of legislative victories last week. Two bills were put before the governor, the first being the removal of the ban on smokable hemp flower. The second was a measure requiring hospitals to allow qualifying patients access to medical marijuana.

Medical marijuana in California hospitals?

Sen. Ben Hueso (D) has been lobbying for terminally ill patient’s right to use medical marijuana in hospitals and medical facilities. The senator recently sent a letter to the U.S. Dept. of Health and Human Services seeking clarification on whether the policy change could potentially affect funding for those facilities.

The progressive bill codifies that hospitals will have the power to allow certain patients to use medical marijuana while in their care. On Thursday, the bill was cleared by the Assembly in a 57-1 vote. On Friday, the Senate signed off on the chamber’s other amendments in a 36-1 vote.

“For many Californians, particularly terminally-ill patients, medicinal cannabis is a preferred alternative to other drugs, providing therapeutic relief without the caveats that may come with other medicines. The bill marks an opportunity for California to continue to lead the way in cannabis regulation and reform,”  Eddie Franco, legislative and regulatory affairs manager at CCIA, told Marijuana Moment.

 


Continue reading

What The Latest Data Says About Cannabis, Drug, And Alcohol Use Among Young People

The latest data on national drug use and health shows that an encouraging trend took place among America’s younger demographic in 2020: pre-teens and teens showed far less interest in using inebriating substances like cannabis, alcohol, and other drugs.

 

According to data provided by the Substance Abuse Mental Health Services Administration (SAMHSA) published earlier this week in the latest National Survey on Drug Use and Health, the use of cannabis among young people fell significantly between 2019 and 2020.

There is plenty of data to show that the rate of cannabis use among youth has fallen consistently as more states legalize cannabis, so the continued drop in use doesn’t come as a surprise. Rates of underage drinking also fell in 2020, as did rates of illicit drug use, including the use of illicit drugs like hallucinogens and cocaine, and the misuse of prescription drugs.

While it seems plausible that the Covid-19 pandemic could be behind lower rates of drug and alcohol use among youth, one shouldn’t discount the growing influence of the sober-curious movement.

Breaking Down The Numbers: Cannabis

When it comes to cannabis, lifetime use among youth aged 12 to 17 dropped from 15.8 percent in 2019 to 12.4 percent in 2020, while past year use fell 25 percent, from 13.2 percent to 10.1 percent. The same age group also saw a 20-percent reduction in past month use compared to 2019.

Close Up Of Teenager Boy Offering Girl Cigarette
Continue reading

NZ Government Backing Medical Cannabis Cultivation Research

New Zealand’s government is tipping in close to NZD $760,000 towards a program seeking to establish evidence-based medical cannabis cultivation practices.

Agriculture Minister Damien O’Connor said as medical cannabis has only been legal in the country since last year, there’s little science-backed information on the best way to cultivate it locally for therapeutically active compounds. These would include cannabidiol (CBD) and tetrahydrocannabinol (THC).

“The aim is to establish sustainable and efficient New Zealand-based medical cultivation practices – with the end goal of sharing the findings with other licensed Kiwi growers,” said Minister O’Connor.

Currently, there are around 37 medicinal cannabis cultivation licences active in the country, and less than 50 hectares under cultivation. The domestic market is almost entirely supplied by imported medicines, which are used to fill around 1,800 prescriptions a month.

“A successful medicinal cannabis industry will earn significant export revenue, provide jobs, and produce locally-grown pharmaceutical options for patients,” stated Minister O’Connor.

e-mail icon
Continue reading

Breast cancer patients using marijuana, not telling doctors, report shows

In an effort to ease the discomfort associated with breast cancer treatment, many patients are using marijuana — and most aren’t telling their doctors. That’s according to a study published earlier this month in the peer-reviewed journal of the American Cancer Society.

The report saw individuals who were members of online health communities on breastcancer.org and Healthline take part in an anonymous survey. It analyzed cannabis use among adults who were diagnosed with breast cancer, which is common in women 65 and older.
Findings showed that 42% of 612 adult breast cancer patients said they used a form of cannabis for symptom relief. Those symptoms included nausea and vomiting, pain, insomnia, anxiety and stress. The majority, 75%, reported that it was extremely or very helpful with providing relief. Of those using cannabis, 79% used it during treatment including systemic therapies, radiation and surgery.
 

Half the participants sought information on medical cannabis. Websites and other patients were reported to be the most helpful sources, while physicians ranked low. Most of those who looked for information on medical marijuana were dissatisfied with the information they obtained. Most people also considered the products safe, unaware that many products’ safety is untested.

“Our study highlights an important opportunity for providers to initiate informed conversations about medical cannabis with their patients, as the evidence shows that many are using medical cannabis without our knowledge or guidance,” lead author Dr. Marisa Weiss, of breastcancer.org and Pennsylvania’s Lankenau Medical Center, said in a press release.

“Not knowing whether or not our cancer patients are using cannabis is a major blind spot in our ability to provide optimal care, and as healthcare providers, we need to do a better job of initiating informed conversations about medical cannabis with our patients to make sure their symptoms and side effects are being adequately managed while minimizing the risk of potential adverse effects, treatment interactions, or non-adherence to standard treatments due to misinformation about the use of medical cannabis to treat cancer,” she added.
Rate this article: 
Select ratingGive Breast cancer patients using marijuana, not telling doctors, report shows 1/5Give Breast cancer patients using marijuana, not telling doctors, report shows 2/5Give Breast cancer patients using marijuana, not telling doctors, report shows 3/5Give Breast cancer patients using marijuana, not telling doctors, report shows 4/5Give Breast cancer patients using marijuana, not telling doctors, report shows 5/5
Authored By: 
Article category: 
Regional Marijuana News: 

e-mail icon

Queerness, cannabis and mental health: everything you need to know

A new set of studies aims to explore how weed affects people from diverse communities, including queer and trans folks

Between the legalization of cannabis in late 2018 and the onset of the COVID-19 pandemic in early 2020, the amount of cannabis Canadians are using is increasing. At the same time, a greater emphasis has been put on mental health as people cope with the loss, isolation and hardship of the pandemic. Yet there are still many gaps in our knowledge of how cannabis use affects our mental health, and debate abounds over whether it is an effective coping tool or a harmful crutch. 

Within the research that does exist, people from diverse communities are under-studied and under-represented, especially LGBTQ2S+ people. To better understand the unique relationship these communities have with cannabis use and mental health, the Mental Health Commission of Canada (MHCC)—in partnership with the Canadian Institute of Health Research, the Canadian Consortium for Early Intervention in Psychosis, the Schizophrenia Society of Canada Foundation and Veterans Affairs Canada—has funded a series of year-long research projects.

Xtra spoke to Mary Bartram, MHCC’s director of policy, who says 18 studies currently in the works are the final set in about 40 research projects MHCC and their partners have funded. The final set—most of which were underway as of September—are qualitative studies highlighting diverse communities, including LGBTQ2S+ populations, racialized and Indigenous people, veterans and people with existing mental health needs. 

“I’m hoping we can really expand the conversation about the relationship between cannabis and mental health, so it’s not just all negative,” Bartram says. “It’s important not to close the door on the possibility of benefits, while at the same time not being naive about risks.” 

While we wait for the studies’ results, here’s what you need to know about the relationship between cannabis and mental health, and the unique needs of diverse populations. 

e-mail icon
Continue reading

New medical marijuana dispensary, opens in Sunnyside

Sunnyside, a new medical marijuana dispensary, is opening in Tallahassee Tuesday morning. 

The dispensary, at 302 N. Monroe St., is hosting a grand opening at 10 a.m. that will feature a ribbon-cutting. 

The 1,500-square-foot store will offer products from the Chicago-based medical marijuana company Cresco Labs' One Plant brand, which includes vapes, lotions and balms. 

This marks the 11th Sunnyside store in the Sunshine State, said Cris Rivera, the Florida regional president of Cresco Labs. 

According to Rivera, the small storefront on North Monroe was purchased by One Plant in 2019. However, before the company broke ground, Cresco Labs bought One Plant's parent company in April and decided to rebrand each store to Sunnyside — including the Tallahassee location.

The modern, sleek look of the black and yellow Sunnyside store is part of Cresco Labs' goal, Rivera said, to normalize and professionalize cannabis use. 

e-mail icon
Continue reading

Too Much Weed Could Increase Your Risk of Breakthrough COVID-19

Experts are zeroing in on what factors might make someone more likely to get a breakthrough COVID case. New research shows smoking weed may be one of them.

Researchers at the National Institute on Drug Abuse (NIDA) find that having a substance use disorder (SUD), especially if using marijuana, can increase one's chances of getting a breakthrough COVID case.1
 
Individuals are diagnosed with SUDs when the recurrent use of a substance, such as alcohol or drugs, causes clinically significant impairment, including health, relationship, and financial problems.2

In the study, vaccinated people without the disorder experienced fewer breakthrough cases than those with a SUD. The risk was also higher depending on the substance people used.

 

What Is Breakthrough COVID-19?

A breakthrough COVID-19 case happens when someone becomes infected with the virus even after being fully vaccinated. COVID-19 in a vaccinated individual can still cause mild or moderate illness, but the chances of a serious case are very low, especially for people who are not living with a chronic health condition.

However, after controlling for other factors, such as underlying health conditions, housing difficulties, and economic hardships, researchers found that the SUDs alone did not account for increased risk—except when it came to cannabis use disorder (CUD). The October study was published in the journal World Psychiatry.

"Those individuals [with CUD] had a significantly greater risk that appeared to come down to the particular substance that was being misused," Pamela B. Davis, MD, PhD, dean of the School of Medicine at Case Western Reserve University and study author, tells Verywell. "But, this is still a very low rate of breakthrough infections. These are very, very good vaccines."
 

What This Means For You

If you or a loved one has been diagnosed with a substance use disorder or uses substances regularly, especially cannabis, it can be helpful to practice extra COVID safety precautions. Getting vaccinated, or getting a booster when it becomes available, can help keep you safe, regardless of whether you limit your substance use.

e-mail icon
Continue reading

Marijuana vaping among teens has more than doubled since 2013

Researchers found that adolescents who say they vaped cannabis within the last 30 days increased 7-fold from 2013 to 2020.

Teen vaping of marijuana doubled between 2013 and 2020, indicating that young people may be swapping out joints, pipes or bongs for vape pens, according to a new study.

Researchers also found that adolescents who say they vaped cannabis within the last 30 days increased 7-fold — from 1.6% to 8.4% — during the same period.

The report was published in JAMA Pediatrics on Monday by researchers who analyzed 17 studies involving nearly 200,000 adolescents in the U.S. and Canada. Overall, they say, the cumulative data points to what may be a shift in preference from dried herb to cannabis oil products, which is how marijuana is ingested via vaping.

This may be due to the more intense high that can be achieved by cannabis oils, which contain higher levels of THC, the psychoactive ingredient in marijuana, and the misconception that vaping devices are safer than smoking.

However, researchers stressed that vaping marijuana poses serious health dangers for teens.

e-mail icon
Continue reading

Can Cannabis Keep Your Brain Young?

New studies are showing that using cannabis can help slow aging in the brain.

The stereotypical weed smoker is depicted as a slow dimwit with the inability to harbor productive thoughts for more than a few seconds. They are motivated by their hedonistic tendencies and want to get “high” as much as possible.

In 2021, we know this is not true considering that almost half of all US adults have tried cannabis at one point in time. While this harmful stereotype was used to deter people from smoking under the assumption that “cannabis negatively impacts the brain” – science is shedding new light on this topic.

Like this PBS Piece on whether cannabis reversed brain aging. The studies are currently being conducted on Mice, meaning that there is not a whole lot of human-evidence to suggest that cannabis helps slow down brain aging- but in mice, the results have been consistent.

One theory is that as we age, we significantly begin to produce fewer endocannabinoids. This affects our endocannabinoid system that is responsible for maintaining homeostasis in the body. The endocannabinoid system helps modulate mood, pain, appetite, immune response and much more.

Therefore, theoretically – since many of our endocannabinoids are similar to the phytocannabinoids found in cannabis – we could see how it could replenish the loss of endocannabinoid production caused by aging.

What did the Mice tell us?

e-mail icon
Continue reading

Rhode Island to Release New Medical Cannabis Dispensary Licenses

Rhode Island’s Department of Business Regulation is rolling out some new medical dispensary licenses to better serve patients in the area.

After a series of delays and legal obstacles, the state of Rhode Island finally appears ready to dole out new licenses for medical marijuana dispensaries.

The state’s Department of Business Regulation announced last week that it will commence a lottery this Friday for five new dispensary licenses. 

In what local television station WPRI described as a “highly choreographed” event, the lottery will take place at the Rhode Island Department of Administration in the capital city of Providence, with limited general seating available to the general public. The lottery will also be livestreamed via Zoom.

The licenses will be awarded to dispensaries from five different geographic zones. WPRI has more details on the event: “A total of 37 applications from 23 companies will be in play for the five coveted licenses. The lottery balls have already been inspected and weighed by experts at the University of Rhode Island and sealed in a briefcase sealed with bomb squad tape since April 30, according to the state’s director of cannabis regulation, Matt Santacroce, who showed the briefcase to reporters Friday morning. A second, practice set of balls was used to demonstrate the procedure.”

The announcement comes on the heels of delays to the lottery process. The lottery was originally scheduled to be held in the first week of August, but that was postponed due to an appeal lodged by an applicant who had been rejected.

Matthew Santacroce, chief of the Office of Cannabis Regulation within the Department of Business Regulation, told the Providence Journal at the time that the lottery would not be conducted “until that appeal has run its course.” 

e-mail icon
Continue reading

Dr. Bronner’s Funds Psilocybin Legalization Effort in Connecticut

Dr. Bronner’s again showed support for psychedelic efforts around the country.

Dr. Bronner’s is pushing for psilocybin reform once again. According to state filings, Washington D.C.-based New Approach PAC, a lobbyist group, funded $14,000 between August and September to local firm Grossman Solutions to promote drug policy reform in Connecticut. Dr. Bronner’s is among New Approach’s biggest donors.

CT Insider reports that a task force in Connecticut is examining the efficacy of psilocybin mushrooms for use in therapeutic settings. House Bill 6296, sponsored by Representative Josh Elliot and four other representatives, created a task force responsible for studying the efficacy of psilocybin for a variety of conditions—a key step in legalizing psilocybin for therapeutic purposes. Grossman Solutions will help New Approach engage with Connecticut’s psilocybin task force.

“New Approach’s mission is to end the senseless and destructive policies of the War on Drugs and replace them with policies that prioritize public health, science, healing and community instead of criminalization,” Ben Unger, director of psychedelic policy for New Approach told CT Insider. “We approach this work knowing that the fight to end the drug war is a political fight, and we need to run professional and strategic political campaigns to make progress.”

The task force examining psilocybin includes several current state legislators, academic researchers, clinicians from Yale, University of Connecticut and Midstate Medical Center, and representatives from several state agencies. It also includes former state representative Jesse MacLachlan.

CEO David Bronner is the grandson of company founder Emil Bronner. He said his goal is to free psychedelics, specifically legalization of psilocybin for therapeutic purposes, adding it’s exactly what his grandfather would have done. “The passion of my grandfather was to unite spaceship earth,” Bronner said. “We honor that legacy in different ways,” among them “integration of psychedelic healing in medicine and therapy.” Bronner also said that he believes “psychedelic medicine can really help people heal and wake up, and grapple with pressing problems.”

The funding arrived with a little bit of luck. Bronner admitted that his company experienced “windfall profits from being a soap business in the time of COVID,” and appropriated $15 million for advocacy—half of which went straight toward drug policy reform.

e-mail icon
Continue reading

West Virginia officials plan medical cannabis signup in Parkersburg

The West Virginia Office of Medical Cannabis will hold a public signup event for medical cannabis patients from 9 a.m. to 4 p.m. Wednesday at the Parkersburg Municipal Building, 1 Government Square.

To sign up, patients who have already been certified by a registered physician as having an applicable serious medical condition must bring the following items: completed patient certification form; driver’s license or state ID; proof of West Virginia residency, such as a utility bill; and a $50 patient ID card application fee, which must be paid by check or money order.

Patients who have not already seen a registered physician must bring the following items, in addition to the above: at least one piece of medical documentation that shows their diagnosis, such as medical records, a letter from a doctor, or office visit summaries; valid photo ID; two proofs of West Virginia residency for state registration; and cash, credit or debit to pay the $149 physician evaluation fee.

Patients who have a household income of 200 percent of the federal poverty level or less may apply for a waiver of the $50 patient ID card fee at the event. If a waiver is requested, applicants must provide their most recent W-2, paystubs within the last 30 days or proof of eligibility for low-income benefits.

Appointments are strongly encouraged and may be scheduled by calling 304-356-5090.

To date, OMC has received 3,862 patient applications for medical cannabis.

Patient cards are valid only in West Virginia. Registration does not mean medical cannabis products can immediately be obtained.

The West Virginia Medical Cannabis Act permits state residents with serious medical conditions to procure medical cannabis for certified medical use in the following forms: pill; oil; topical forms including gels, creams or ointments; a form medically appropriate for administration by vaporization or nebulization; dry leaf or plant form; tincture; liquid; or dermal patch.

e-mail icon
Continue reading

What Experts Want You To Know About Putting CBD On Your Skin

The argument could be made that CBD has effectively replaced THC as the most famous three-letter acronym associated with cannabis at the moment. But let’s not get the two mixed up. CBD is short for cannabidiol, one of the compounds found in cannabis plants. Hemp and marijuana both belong to the cannabis plant family, and while they have their differences (more on that later!), CBD can be derived from either. The other compound found in cannabis plants is THC. THC gets you high, but CBD doesn't. Not even close.

It’s everywhere: body lotion, bath salts, supplements, sleep aids, even dog food (seriously). And don't get me started on CBD in skin care. It seems every other email in my inbox is a press release announcing “something dank is about to drop” or telling me to “take a hit” of a new serum. Anyone else feeling a little, uh, “burnt out” on the whole thing?

With all that said, you probably don’t need another article touting the purported benefits of CBD oil for your skin (though, sure, I’ll cover the basics). Instead, here's the stuff about CBD that no one else is telling you — from sourcing to social impact to financial practices — straight from industry insiders. If you're thinking of working CBD into your beauty routine, read this first.

CBD Basics

Although more research needs to be done around how CBD works and its ability to manage specific issues (like anxiety and insomnia, for instance), there are a few key points many industry experts seem to agree on. “CBD acts as an analgesic and anti-inflammatory,” Cindy Capobianco, the co-founder and president of CBD company Lord Jones, tells TZR. “CBD has been used for centuries to successfully relieve pain and treat skin conditions such as eczema, psoriasis, and rosacea — even sunburn and bug bites — when used topically.” Studies suggest that, when ingested, those same properties can have a slightly different effect. “It has the additional benefits of mood stabilization, relief from anxiety, and promoting a calm sense of well-being,” Capobianco says.

How, exactly, does it do this? Experts say that comes down to the endocannabinoid system, or ECS. “The ECS is a network of receptors found throughout every mammal,” a representative from Dosist, a company known for its CBD dose pens, tells TZR. “This system is responsible for maintaining the body’s homeostasis, or balance, and helps regulate everything from sleep, to pain, to appetite, to immune function, to stress.” Studies seem to indicate that the body is pretty much primed to thrive on CBD — it naturally produces endocannabinoids, and CBD is a related phytocannabinoid. Both apparently affect the ECS in similar ways. “It’s often described as a lock and key system, where the cannabinoid is the key ‘unlocking’ a receptor, causing a series of reactions throughout the body,” Dosist explains. There's evidence to suggest this can lead to less anxiety, better sleep, reduced inflammation, calm skin, et al.

“Some studies have shown that topical CBD can also help reduce oil production in addition to reducing inflammation in the skin, which are two main players in the generation of acne,” Dr. Jennifer Vickers, a dermatologist with Sanova Dermatology in Texas, tells TZR, adding that the anti-inflammatory effects of CBD oil on the skin can help calm and reduce redness, too. “It also has antioxidant and regenerative qualities to help offset damage from the sun, pollution, and aging.” Basically, it seems everyone’s complexion can stand to benefit from an application of cannabidiol.

How CBD oil for your skin works
Continue reading

Olivia Newton-John discusses cannabis use in cancer battle update

Olivia Newton-John has provided a health update as she battles cancer.

livia Newton-John has opened up on USA TODAY overnight about her ongoing health battle with cancer revealing cannabis use has been a huge part of her healing.  (Image Source: Getty Images.)

Newton-John was first diagnosed with cancer in 1992, overcoming the disease in 2013 only for cancer to metastasize in May 2017 and spread to her bones.

The Grease star, 73, spoke with Hoda Kotb on TODAY, providing a health update while discussing managing her pain with medical marijuana provided by her husband.

“Right now I’m feeling pretty good,” she said.

“I have my days, I have my pains, but the cannabis that my husband grows for me has been such a huge part of my healing, and so I’m a really lucky person.”
The two bonded during the interview after Newton-John learnt of Kotb’s own battle with cancer 14 years ago, Newton-John offered her support asking the host, “so you’re well now you’re doing good?” and referring to the pair as “sisters”.

“I’m really sorry you went through that,” Newton-John said.

e-mail icon
Continue reading

Medical marijuana firm spends $170M to expand into Lancaster, Mount Joy, elsewhere

A Chicago-based medical marijuana company is spending $170 million to expand in Pennsylvania through a pair of acquisitions which include a Lancaster dispensary and a Mount Joy growing-and-processing operation.

Cresco Labs recently agreed to buy three Cure Penn dispensaries, including one here on Fruitville Pike in the former Kmart Plaza, plus dispensaries in Philadelphia and Phoenixville (near King of Prussia) for $90 million.

The Fruitville Pike store is the county’s oldest dispensary, opening in March 2018 and operating seven days a week. It has nearly 20 employees.

The Cure Penn dispensaries will join Cresco Labs’ five dispensaries operating under the Sunnyside brand, including a Wyomissing location that opens today.

“We’re continuously focused on normalizing the cannabis-buying experience,” said William Butler, Cresco Labs’ senior vice president for retail, in a prepared statement. “Our goal is for patients who prioritize their health and wellness to feel as comfortable buying cannabis products as they do visiting a supermarket or fitness center.”

The acquisition is expected to be completed by year-end. When that happens, the three Cure Penn dispensaries will become Sunnyside locations. However, they already carry some Cresco Labs products, including the Cresco, Remedi and Good News brands, as Cresco Labs is the largest wholesaler of brand cannabis products in the U.S.

e-mail icon
Continue reading

Police warn of marijuana edibles that look like candy ahead of Halloween

 

Scam artists are giving a whole new meaning to trick or treat. With Halloween around the corner, police want you to take extra precautions to keep children safe.

 

 

Law enforcement agencies are asking parents to check every piece of candy their child receives. Be on the lookout for tampered treats or marijuana edibles inside packing that appeals to kids.

Marijuana edibles can easily be mistaken for regular candy. The bright & color packaging appeals to kids.

Roseville police busted a gas station for selling edibles that are lookalikes for Warheads and Gushers.

e-mail icon
Continue reading

Advisory issued after chemically-altered THC found in medical marijuana

The Oklahoma Medical Marijuana Authority issued a patient advisory recently after confirming the presence of THC analogs, including THC-O-acetate, in a rising number of medical marijuana products.  

According to the OMMA, the manufactured THC compound is not a medical marijuana product and has been shown to be harmful when added to products already containing THC. Side effects can include seizures, difficulty speaking and vomiting.  

Metis, the OMMA’s quality assurance lab, is monitoring for the presence of this chemical compound in a concentrate known as Platinum OG Sugar in surveillance samples.

Kelsey Pagonis, OMMA communications manager, said that THC-O-acetate can be one to three times as potent as naturally occurring THC. 

“It’s very intentional. It’s a dangerous process to make THC-O-acetate. This isn’t something that happens by accident,” she said.  

e-mail icon
Continue reading

Ohio medical marijuana users say prices still too high

It’s been nearly three years since the first medical marijuana dispensary opened in Ohio and a little more than half of the state’s marijuana card holders are either “extremely dissatisfied” or “somewhat dissatisfied” with the program.

That’s just one of the results of a recent report prepared by the Drug Enforcement and Policy Center at Ohio State University’s Moritz College of Law, which supports and promotes research, education and public engagement on topics surrounding drug policy and enforcement and tracks the state’s medicinal cannabis program.
 
The high price of marijuana in Ohio dispensaries was the top reason for their continued dissatisfaction, for not using licensed dispensaries and for opting out of using medical marijuana, according to the 1,326 patients responding to survey questions.
 
The price of marijuana in Ohio, continues to be considerably higher than in neighboring Michigan. Through the first half of 2021 the per-gram price of marijuana in Ohio was 44% more expensive than in Michigan. It’s also significantly lower than in Pennsylvania, according to the report.
 
“We follow the economic trends because you don’t want (the price) to be too low or too high, so there’s a median that has been set by the industry,” said Ariane Kirkpatrick, CEO of Harvest of OH, which opened a new 2,936-square-foot medical marijuana dispensary last week in Beavercreek. “Everybody’s selling pretty much at the same price, all of the locations. There’s no price-gauging by any individual owners.”

There’s also an understanding among owners to not undersell it “just so they can get all the sales,” Kirkpatrick said.

“That happens in other industries, but I think there’s a respect among all of the owners to sell for what the going rate is, she said.
 
The price of plant product in Ohio dispensaries actually has decreased since the beginning of 2019, when it started at around $17 per gram, according to the survey report. Yet the price has not fluctuated much since January 2020, “hovering mostly between $10 and $11 per gram despite an increase in the number of cultivators and dispensaries.”

The price of medical marijuana may appear to be high because insurance does not cover it, according to Matt Close, executive director for the Ohio Medical Cannabis Industry Association. That should change as compliance and regulatory burdens are addressed and as the market matures, he said.

“We’ve got more dispensaries coming now, more retailers, more access to product,” Close told this news outlet.

Another reason for dissatisfaction mentioned by patients via the survey was a lack of home grow options in the state.

Cannabis for Cures sued the state of Ohio for allegedly not upholding the medical marijuana laws correctly. Laura Bischoff/Staff
Continue reading

Oklahoma Medical Marijuana Authority warning of potentially dangerous compound

he Oklahoma Medical Marijuana Authority has issued a warning about a potentially dangerous compound circulating in the state.

The agency is investigating reports that the compound, THC-O-acetate, was found in at least one batch, possibly more.

THC-O-acetate is at least three times more potent than THC and can be harmful if combined with medical marijuana.

Possible side effects include seizures, vomiting, and difficulty speaking.

OMMA says when purchasing a medical marijuana product from a licensed dispensary, always ask to see the Certificates of Analysis and examine the lab test results so you can ensure you’re taking a safe product home.

e-mail icon
Continue reading

Case study: Can CBD oil shrink lung cancer tumors?

Cannabinoids are chemical compounds presentTrusted Source in the Cannabis sativa (C. sativa) plant. Some people use cannabis therapeutically to treat seizures, pain, inflammation, spasms, and anxiety.

CBD and delta-9-tetrahydrocannabinol (THC) are the two major cannabinoids present in the cannabis plant. However, CBD does not produce a euphoric feeling, or “high,” that people associate with cannabis use.

CBD oil is a concentrated extract derived from cannabis leaves or flowers dissolved in a consumable oil, such as olive, hemp, or sunflower oil. There are different types of CBD oil containing various concentrations of cannabinoids.

CBD isolates contain CBD alone. Full-spectrum CBD products contain compounds from all parts of the C. sativa plant, with less than 0.3% THC.

Broad-spectrum CBD products include most of the same compounds as full-spectrum ones but only trace amounts of THC.

e-mail icon
Continue reading

WeedLife.com